Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study
- PMID: 19091352
- DOI: 10.1016/j.juro.2008.10.025
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study
Abstract
Purpose: We explored risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in the open population.
Materials and methods: A longitudinal, population based study with a followup of 6.5 years was done in 1,688 men who were 50 to 78 years old. Data were collected on transrectal ultrasound of prostate volume, urinary flow rate, ultrasound estimated post-void residual urine volume, generic and disease specific quality of life, and symptom severity based on the International Prostate Symptom Score. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia were defined as an International Prostate Symptom Score of greater than 7 after a report of a score of less than 7 in the previous round. A multivariate Cox proportional hazard model was constructed to determine risk factors for clinical benign prostatic hyperplasia after correcting for patient age.
Results: Total followup was 4,353 person-years. During followup 180 events of attaining an International Prostate Symptoms Score of greater than 7 occurred. Multivariate analysis showed that functional bladder capacity, post-void residual urine volume, treatment for cardiac diseases, education level, antidepressant use, calcium antagonist use, erectile function or dysfunction, prostate specific antigen and a family history of prostate cancer were determinants with a significant HR.
Conclusions: In addition to age, we established 9 significant determinants for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. However, not all risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia are accounted for since we can conclude that 1 of 3 men without these risk factors will still be diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia between ages 50 and 80 years.
Similar articles
-
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22. J Urol. 2008. PMID: 18722631 Clinical Trial.
-
Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.J Urol. 2006 Sep;176(3):1051-6. doi: 10.1016/j.juro.2006.04.044. J Urol. 2006. PMID: 16890690
-
Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.Urology. 2004 Mar;63(3):476-80. doi: 10.1016/j.urology.2003.10.021. Urology. 2004. PMID: 15028441
-
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561143 Review.
-
Prevention of benign prostatic hyperplasia disease.J Urol. 2006 Oct;176(4 Pt 1):1299-306. doi: 10.1016/j.juro.2006.06.022. J Urol. 2006. PMID: 16952616 Review.
Cited by
-
Sexual function outcome following photoselective vaporisation of the prostate.Int Urol Nephrol. 2012 Apr;44(2):359-64. doi: 10.1007/s11255-011-0029-4. Epub 2011 Jul 21. Int Urol Nephrol. 2012. PMID: 21779921
-
Global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021 and projection to 2035.BMC Urol. 2025 Feb 19;25(1):34. doi: 10.1186/s12894-025-01715-9. BMC Urol. 2025. PMID: 39972318 Free PMC article.
-
Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.Sci Rep. 2016 Sep 22;6:33933. doi: 10.1038/srep33933. Sci Rep. 2016. PMID: 27653367 Free PMC article.
-
Epidemiology of clinical benign prostatic hyperplasia.Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004. Epub 2017 Jun 9. Asian J Urol. 2017. PMID: 29264223 Free PMC article. Review.
-
Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context.Glob Reg Health Technol Assess. 2025 Jul 22;12:177-185. doi: 10.33393/grhta.2025.3401. eCollection 2025 Jan-Dec. Glob Reg Health Technol Assess. 2025. PMID: 40698355 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical